Thermo Fisher Scientific (TMO) Change in Acquisitions & Divestments (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Change in Acquisitions & Divestments for 10 consecutive years, with $3.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Acquisitions & Divestments fell 25.0% year-over-year to $3.0 million; the trailing twelve-month figure through Jun 2026 stood at $1.8 billion (up 2.34% YoY), and the FY2025 full-year result was $1.6 billion, down 11.58% from the prior year.
• Change in Acquisitions & Divestments slipped to $3.0 million in Q2 2026 per TMO's latest filing, from $250.0 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $1.8 billion in Q4 2024 and bottomed at $2.0 million in Q1 2025.
• Historically, Change in Acquisitions & Divestments has averaged $511.3 million across 3 years, with a median of $248.0 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Change in Acquisitions & Divestments declined 25.55% in 2025, then soared 12400.0% in 2026.
• Over 3 years, Change in Acquisitions & Divestments stood at $1.8 billion in 2024, then slipped by 25.55% to $1.3 billion in 2025, then sank by 99.77% to $3.0 million in 2026.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $3.0 million, $250.0 million, and $1.3 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.